A Meta-Analysis of Clinical Outcomes After Radiofrequency Ablation and Microwave Ablation for Lung Cancer and Pulmonary Metastases

Yuan, Zhuhui; Wang, Yang; Zhang, Junfeng Jim; Zheng, Jiasheng; Li, Wei

doi:10.1016/j.jacr.2018.10.012

Cited by 70 publications

(70 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…20 This comes with the caveat that MWA is theoretically more likely to injure surrounding vessels, though no significant differences in complications have been documented between the two heat-based ablation modalities. 26,27 Finally, MWA appears to be safer than RFA when used in patients with implantable cardiac devices. 28…”

Section: Selectionmentioning

confidence: 99%

Microwave Ablation in Primary Lung Malignancies

Moussa

Ziv

Solomon

et al. 2019

Semin intervent Radiol

View full text Add to dashboard Cite

Lung cancer is the leading cause of cancer-related mortality worldwide. Eighty-five percent of cases correspond to non-small cell lung cancer (NSCLC) and pivotal nonsurgical options for early-stage disease include percutaneous ablation and stereotactic body radiation therapy (SBRT). Microwave Ablation (MWA) is a locoregional treatment option that has many advantages over radiofrequency ablation and has been able to overcome the limitations of this technique in the treatment of early-stage NSCLC. In this review article, we highlight the current evidence supporting the use of MWA in patients with early-stage NSCLC and discuss the technical considerations of the procedure, including optimal patient selection and planning strategies, as well as the potential complications and reported outcomes. Finally, we mention future trends involving ablation in NSCLC, including its role in combination with SBRT in central tumors, management of post-SBRT local recurrence, and its potential as an adjuvant treatment option for patients with resistance to systemic therapy or in combination with checkpoint inhibitors.

show abstract

Section: Selectionmentioning

confidence: 99%

Microwave Ablation in Primary Lung Malignancies

Moussa

Ziv

Solomon

et al. 2019

Semin intervent Radiol

View full text Add to dashboard Cite

show abstract

“…With regard to complications, pneumothorax is one of the most common complications associated with RFA. However, it is most often (>80%) treated conservatively without the need for chest tube drainage [75]. In addition, pleural effusion might develop after RFA, however, similar to pneumothorax, does not often (<5%) require intervention [75].…”

Section: Radiofrequency Ablation (Rfa)mentioning

confidence: 99%

“…However, it is most often (>80%) treated conservatively without the need for chest tube drainage [75]. In addition, pleural effusion might develop after RFA, however, similar to pneumothorax, does not often (<5%) require intervention [75]. In summary, RFA therapy seems an effective and relatively safe intervention for treating lung cancer, however, a careful patient selection is necessary.…”

Section: Radiofrequency Ablation (Rfa)mentioning

confidence: 99%

“…Studies and long-term data after MWA as a thermal ablation modality are limited when compared with RFA. In a recent review, Yuan and colleagues reported a meta-analysis of clinical outcomes after RFA and MWA for primary and metastatic pulmonary malignancies [75]. The authors identified 11 studies based on MWA compared with 42 studies based on RFA therapy, all with a retrospective study design.…”

Section: Microwave Ablation (Mwa)mentioning

confidence: 99%

“…In addition, similar to RFA, MWA is a relatively safe intervention which is not associated with high complication rates. Yuan et al reported comparable rates of pneumothorax and pleural effusion after ablation by MWA and RFA [75]. Concerning prognostic factors negatively affecting survival and local tumor progression control, more advanced disease stage, tumors >3 cm (diameter), and emphysematous lungs have been identified [78].…”

Section: Microwave Ablation (Mwa)mentioning

confidence: 99%

See 2 more Smart Citations

The Realm of Oncological Lung Surgery: From Past to Present and Future Perspectives

Maat¹,

Sadeghi²,

Bogers³

et al. 2020

Update in Respiratory Diseases

View full text Add to dashboard Cite

In this chapter, a historical overview as well as an overview of state of the art of the surgical techniques for the treatment of lung cancer is outlined. The chapter focuses on the introduction of open surgery, video-assisted thoracic surgery (VATS), uniportal VATS (UVATS), and robotic-assisted thoracic surgery (RATS) techniques for lung resections. A short introduction on upcoming techniques and modalities is given. The currently available tools as three-dimensional (3D) computed tomography (CT), virtual reality, and endo-bronchial surgery will be discussed. Based on the current development, this chapter attempts to delineate the horizon of oncological lung surgery. The information is generated not only from the available literature, but also from the experiences of surgeons and other physicians as well as co-workers involved in lung cancer treatment around the world. This chapter can be seen as a general introduction to several aspects of oncological lung surgery.

show abstract

Role of surgical resection and its alternative local therapy for pulmonary metastasis of colorectal cancer

Ogawa

Yajima

Sohda

et al. 2021

Annals of Gastroent Surgery

View full text Add to dashboard Cite

We reviewed surgical and alternative treatments for pulmonary metastasis of colorectal cancer, focusing on recent reports. The standard treatment for pulmonary metastasis of colorectal cancer is pulmonary resection, if resectable, despite the fact that the metastasis is hematogenous to distant organs. Guidelines in several countries, including Japan, have described pulmonary resection as a useful option because of the favorable long‐term prognosis reported in various studies pertaining to pulmonary resection. The indications for pulmonary resection have been reviewed in several studies; additionally, the number of metastases, pretreatment carcinoembryonic antigen value, and disease‐free interval from the primary resection to pulmonary recurrence have been proposed. However, no consensus has been reached to date. Contrastingly, recent advances in chemotherapy have remarkably improved the outcome of distant metastases, indicating that it is time to reconsider the significance of local treatment, including pulmonary resection. In addition to surgical resection, minimally invasive therapies, such as stereotactic body radiation therapy and radiofrequency ablation have been developed as local treatments for pulmonary metastases, and their long‐term results have been reported. Prospective controlled trials and large‐scale data analyses are needed to determine the best local treatment for pulmonary metastases and to find the appropriate indication for each treatment.

show abstract

A Meta-Analysis of Clinical Outcomes After Radiofrequency Ablation and Microwave Ablation for Lung Cancer and Pulmonary Metastases

Cited by 70 publications

References 58 publications

Microwave Ablation in Primary Lung Malignancies

Microwave Ablation in Primary Lung Malignancies

The Realm of Oncological Lung Surgery: From Past to Present and Future Perspectives

Role of surgical resection and its alternative local therapy for pulmonary metastasis of colorectal cancer

Contact Info

Product

Resources

About